Kinetic_JJ comparison_NN of_IN tissue_NN non-specific_JJ and_CC placental_JJ human_JJ alkaline_JJ phosphatases_NNS expressed_VBN in_IN baculovirus_JJ infected_JJ cells_NNS :_: application_NN to_TO screening_NN for_IN Down_NP 's_POS syndrome_NN Abstract_NP |_SYM Background_NN |_SYM In_IN humans_NNS ,_, there_EX are_VBP four_CD alkaline_JJ phosphatases_NNS ,_, and_CC each_DT form_NN exibits_VBZ a_DT characteristic_JJ pattern_NN of_IN tissue_NN distribution_NN ._SENT The_DT availability_NN of_IN an_DT easy_JJ method_NN to_TO reveal_VB their_PP$ activity_NN has_VBZ resulted_VBN in_IN large_JJ amount_NN of_IN data_NNS reporting_VBG correlations_NNS between_IN variations_NNS in_IN activity_NN and_CC illnesses_NNS ._SENT For_IN example_NN ,_, alkaline_JJ phosphatase_NN from_IN neutrophils_NNS of_IN mothers_NNS pregnent_JJ with_IN a_DT trisomy_JJ 21_CD fetus_NN (_( Down_NP 's_POS syndrome_NN )_) displays_VBZ significant_JJ differences_NNS both_CC in_IN its_PP$ biochemical_JJ and_CC immunological_JJ properties_NNS ,_, and_CC in_IN its_PP$ affinity_NN for_IN some_DT specific_JJ inhibitors_NNS ._SENT Results_NNS |_SYM To_TO analyse_VB these_DT differences_NNS ,_, the_DT biochemical_JJ characteristics_NNS of_IN two_CD isozymes_NNS (_( non_JJ specific_JJ and_CC placental_JJ alkaline_JJ phosphatases_NNS )_) were_VBD expressed_VBN in_IN baculovirus_JJ infected_JJ cells_NNS ._SENT Comparative_JJ analysis_NN of_IN the_DT two_CD proteins_NNS allowed_VBD us_PP to_TO estimate_VB the_DT kinetic_JJ constants_NNS of_IN denaturation_NN and_CC sensitivity_NN to_TO two_CD inhibitors_NNS (_( L-p-bromotetramisole_NP and_CC thiophosphate_NN )_) ,_, allowing_VBG better_JJR discrimination_NN between_IN the_DT two_CD enzymes_NNS ._SENT These_DT parameters_NNS were_VBD then_RB used_VBN to_TO estimate_VB the_DT ratio_NN of_IN the_DT two_CD isoenzymes_NNS in_IN neutrophils_NNS of_IN pregnant_JJ mothers_NNS with_IN or_CC without_IN a_DT trisomy_JJ 21_CD fetus_NN ._SENT It_PP appeared_VBD that_IN the_DT placental_JJ isozyme_NN represented_VBD 13_CD %_NN of_IN the_DT total_JJ activity_NN of_IN neutrophils_NNS of_IN non_JJ pregnant_JJ women_NNS ._SENT This_DT proportion_NN did_VBD not_RB significantly_RB increase_VB with_IN normal_JJ pregnancy_NN ._SENT By_IN contrast_NN ,_, in_IN pregnancies_NNS with_IN trisomy_NN 21_CD fetus_NN ,_, the_DT proportion_NN reached_VBN 60_CD --_: 80_CD %_NN of_IN activity_NN ._SENT Conclusion_NN |_SYM Over-expression_NN of_IN the_DT placental_JJ isozyme_NN compared_VBN with_IN the_DT tissue-nonspecific_JJ form_NN in_IN neutrophils_NNS of_IN mother_NN with_IN a_DT trisomy_JJ 21_CD fetus_NN may_MD explain_VB why_WRB the_DT characteristics_NNS of_IN the_DT alkaline_JJ phosphatase_NN in_IN these_DT cells_NNS is_VBZ different_JJ from_IN normal_JJ ._SENT Application_NN of_IN this_DT knowledge_NN could_MD improve_VB the_DT potential_NN of_IN using_VBG alkaline_JJ phosphatase_NN measurements_NNS to_TO screen_VB for_IN Down_NP 's_POS syndrome_NN ._SENT Alkaline_JJ phosphatase_NN (_( AP_NP ,_, orthophosphoric_JJ monoester_NN phosphohydrolase_NN ,_, alkaline_JJ optimum_NN ,_, EC_NP 3.1.3.1_CD )_) is_VBZ a_DT group_NN of_IN ubiquitous_JJ enzymes_NNS found_VBN in_IN nearly_RB every_DT organ_NN ._SENT So_RB far_RB ,_, four_CD different_JJ human_JJ isoenzymes_NNS have_VBP been_VBN identified_VBN :_: the_DT tissue_NN non-specific_JJ isozyme_NN (_( NSAP_NP )_) is_VBZ expressed_VBN in_IN numerous_JJ tissues_NNS ,_, while_IN the_DT three_CD specific_JJ genes_NNS have_VBP more_RBR restrictive_JJ expression_NN :_: in_IN intestin_NN (_( intestinal_JJ AP_NP ;_: )_) ,_, placenta_NN (_( PLAP_NP ;_: )_) or_CC thymus_NN and_CC testis_NN (_( germ-cell_NN AP_NP ;_: )_) ._SENT AP_NP are_VBP zinc-containing_JJ dimeric_JJ proteins_NNS which_WDT catalyze_VBP the_DT hydrolysis_NN of_IN phosphomonoester_NN with_IN release_NN of_IN inorganic_JJ phosphate_NN and_CC alcohol_NN at_IN alkaline_JJ pH_NN ._SENT The_DT catalytic_JJ mechanism_NN was_VBD first_RB deduced_VBN from_IN the_DT structure_NN of_IN the_DT bacterial_JJ enzyme_NN and_CC was_VBD recently_RB confirmed_VBN from_IN the_DT structure_NN of_IN a_DT human_JJ isozyme_NN ._SENT It_PP involves_VBZ the_DT activation_NN of_IN a_DT serine_NN by_IN a_DT zinc_NN atom_NN ,_, the_DT formation_NN of_IN a_DT phosphorylenzyme_NN ,_, the_DT hydrolysis_NN of_IN the_DT phosphoseryl_NN by_IN a_DT water_NN molecule_NN activated_VBN by_IN a_DT second_JJ zinc_NN atom_NN and_CC the_DT release_NN of_IN the_DT phosphate_NN or_CC its_PP$ transfer_NN to_TO an_DT acceptor_NN ._SENT Four_CD main_JJ catalytic_JJ functions_NNS have_VBP been_VBN attributed_VBN to_TO these_DT enzymes_NNS ,_, hydrolase_NN activity_NN on_IN low_JJ molecular_JJ weight_NN phosphomonoesters_NNS ,_, phosphotransferase_NN activity_NN ,_, protein_NN phosphatase_NN activity_NN and_CC pyrophosphatase_NN activity_NN ._SENT The_DT physiological_JJ role_NN of_IN AP_NP is_VBZ poorly_RB known_VBN ,_, except_IN for_IN the_DT involvement_NN of_IN the_DT NSAP_NP isoenzyme_NN in_IN the_DT mineralisation_NN of_IN bone_NN tissue_NN ._SENT In_IN blood_NN ,_, only_RB NSAP_NP is_VBZ found_VBN in_IN the_DT serum_NN and_CC in_IN neutrophils_NNS ._SENT These_DT cells_NNS contain_VBP a_DT wide_JJ variety_NN of_IN enzymes_NNS functionally_RB active_JJ in_IN host_NN defense_NN ._SENT Among_IN them_PP AP_NP ,_, probably_RB serving_VBG in_IN membrane_NN upregulation_NN ,_, has_VBZ been_VBN identified_VBN in_IN specific_JJ inclusions_NNS ,_, the_DT secretory_JJ granules_NNS ,_, representing_VBG a_DT highly_RB mobilizable_JJ storage_NN compartment_NN ._SENT AP_NP is_VBZ detectable_JJ in_IN differentiated_VBN granulocytes_NNS ,_, including_VBG myelocytes_NNS ,_, meta_NN myelocytes_NNS ,_, band_NN forms_NNS and_CC segmented_VBN neutrophils_NNS ._SENT With_IN pregnancy_NN ,_, AP_NP increases_NNS in_IN the_DT serum_NN ._SENT This_DT phenomenon_NN originates_VBZ from_IN the_DT PLAP_NN synthesized_VBN in_IN the_DT placenta_NN from_IN the_DT 7th_JJ week_NN of_IN pregnancy_NN which_WDT passes_VBZ into_IN the_DT mothers_NNS serum_NN [_SYM ,-_NN ]_SYM ._SENT Besides_IN this_DT activity_NN in_IN the_DT serum_NN ,_, the_DT AP_NP activity_NN also_RB increases_VBZ in_IN the_DT neutrophils_NNS of_IN pregnant_JJ women_NNS ,_, but_CC it_PP is_VBZ the_DT NSAP_NP isozyme_NN which_WDT is_VBZ responsible_JJ ._SENT As_IN yet_RB ,_, little_RB is_VBZ known_VBN of_IN the_DT mechanisms_NNS regulating_VBG AP_NP activity_NN during_IN the_DT course_NN of_IN normal_JJ gestation_NN ._SENT Three_CD distinct_JJ mechanisms_NNS presumably_RB act_VBP in_IN combination_NN to_TO elicit_VB AP_NP activity_NN :_: i_NP )_) the_DT physiological_JJ hyperleucocytosis_NN occurring_VBG with_IN a_DT steady_JJ increase_NN in_IN leucocyte_NN count_NN during_IN pregnancy_NN ;_: ii_NP )_) the_DT rise_NN in_IN placental_JJ hormonal_JJ secretions_NNS ,_, estrogen_NN and_CC mainly_RB progesterone_NN ,_, results_NNS in_IN an_DT increase_NN in_IN AP_NP activity_NN correlated_VBN with_IN an_DT elevation_NN of_IN steady_JJ state_NN mRNA_NN levels_NNS as_IN a_DT consequence_NN of_IN enhanced_JJ gene_NN transcription_NN ;_: iii_NP )_) the_DT induction_NN by_IN granulocyte_NN colony_NN stimulating_VBG factor_NN (_( G-CSF_NP )_) ,_, one_CD of_IN the_DT most_RBS important_JJ modulators_NNS responsible_JJ for_IN NAP_NP activity_NN ._SENT The_DT characteristics_NNS of_IN AP_NP from_IN blood_NN neutrophils_NNS of_IN women_NNS whose_WP$ fetuses_NNS had_VBD trisomy_NN 21_CD differ_VBP from_IN those_DT with_IN normal_JJ pregnancies_NNS ._SENT An_DT elevated_JJ AP_NP activity_NN has_VBZ been_VBN reported_VBN in_IN affected_JJ individuals_NNS ._SENT An_DT ectopic_JJ expression_NN of_IN PLAP_NP seems_VBZ to_TO appear_VB since_IN i_NP )_) AP_NP is_VBZ more_RBR stable_JJ to_TO heat_NN and_CC urea_NN denaturation_NN ,_, ii_NP )_) AP_NP is_VBZ more_RBR sensitive_JJ to_TO inhibitors_NNS L-homo-arginine_NP ,_, EDTA_NP ,_, L-phenylalanine_NP ,_, L-p-bromotetramisole_NP and_CC sodium_NN thiophosphate_NN and_CC iii_NN )_) AP_NP is_VBZ less_RBR recognized_VBN by_IN anti-NSAP_NP antibodies_NNS and_CC shows_VBZ a_DT reaction_NN with_IN anti-PLAP_NN antibodies_NNS ._SENT These_DT variations_NNS in_IN the_DT respective_JJ levels_NNS of_IN expression_NN of_IN NSAP_NP and_CC PLAP_NP in_IN serum_NN and_CC neutrophils_NNS can_MD lead_VB to_TO these_DT enzymes_NNS being_VBG used_VBN as_IN markers_NNS to_TO detect_VB trisomy_NN 21_CD fetuses_NNS ._SENT However_RB ,_, this_DT method_NN has_VBZ been_VBN reported_VBN to_TO be_VB controversial_JJ while_IN others_NNS found_VBD it_PP to_TO be_VB reliable_JJ ._SENT This_DT discrepancy_NN may_MD originate_VB from_IN the_DT difficulty_NN of_IN separating_VBG the_DT two_CD isozymes_NNS ,_, NSAP_NP and_CC PLAP_NP ._SENT Thus_RB ,_, we_PP studied_VBD some_DT of_IN their_PP$ properties_NNS after_IN in_IN vitro_NN production_NN of_IN recombinant_JJ enzymes_NNS in_IN baculovirus_JJ infected_JJ cells_NNS in_IN order_NN to_TO provide_VB data_NNS useful_JJ to_TO differentiate_VB the_DT two_CD isozymes_NNS ._SENT Comparisons_NNS of_IN enzyme_NN stability_NN |_SYM Enzymes_NNS were_VBD denatured_VBN by_IN urea_NN and_CC by_IN heating_NN ._SENT In_IN the_DT presence_NN of_IN urea_NN ,_, we_PP observed_VBD a_DT decrease_NN of_IN active_JJ enzyme_NN concentration_NN until_IN a_DT plateau_NN suggesting_VBG that_IN the_DT denaturation_NN was_VBD reversible_JJ ._SENT Thus_RB ,_, the_DT kinetic_JJ of_IN denaturation_NN was_VBD analyzed_VBN with_IN scheme_NN 1_CD ,_, Figure_NP 2_CD |_SYM Inactivation_NN of_IN alkaline_JJ phosphatase_NN by_IN urea_NN :_: effect_NN of_IN incubation_NN of_IN PLAP_NP and_CC NSAP_NP with_IN 7.4_CD M_NN urea_NN on_IN activity_NN ._SENT Inactivation_NN of_IN alkaline_JJ phosphatase_NN by_IN urea_NN :_: effect_NN of_IN incubation_NN of_IN PLAP_NP and_CC NSAP_NP with_IN 7.4_CD M_NN urea_NN on_IN activity_NN ._SENT where_WRB E_NP represents_VBZ the_DT native_JJ enzyme_NN ,_, Ed_NP the_DT inactive_JJ denatured_VBN enzyme_NN ,_, kd_VBG the_DT denaturation_NN rate_NN constant_JJ and_CC kr_NN the_DT renaturation_NN rate_NN constant_JJ ._SENT The_DT variation_NN of_IN remaining_VBG activity_NN (_( E/E0_NP )_) with_IN time_NN t_NN follows_VBZ equation_NN 1_CD :_: Analysis_NN of_IN data_NNS by_IN non-linear_JJ regression_NN gave_VBD an_DT estimation_NN of_IN the_DT two_CD rate_NN constants_NNS kd_NN and_CC kr_NN for_IN the_DT two_CD enzymes_NNS ._SENT The_DT renaturation_NN rate_NN constant_JJ (_( kr_NN )_) was_VBD significantly_RB different_JJ from_IN zero_CD confirming_VBG the_DT reversibility_NN of_IN the_DT urea_NN denaturation_NN ._SENT Placental_JJ AP_NP appeared_VBD to_TO be_VB more_RBR resistant_JJ to_TO urea_NN denaturation_NN than_IN NSAP_NP while_IN the_DT renaturation_NN rate_NN constants_NNS were_VBD not_RB significantly_RB different_JJ ._SENT The_DT heat_NN denaturation_NN rate_NN differed_VBD between_IN the_DT two_CD enzymes_NNS at_IN the_DT all_DT temperature_NN assayed_VBD ._SENT Denaturation_NN was_VBD irreversible_JJ and_CC the_DT simplest_JJS model_NN which_WDT fitted_VBD to_TO the_DT data_NN is_VBZ illustrated_VBN by_IN scheme_NN 2_CD ,_, where_WRB Ed_NP represents_VBZ the_DT irreversible_JJ form_NN of_IN the_DT denatured_VBN enzyme_NN ._SENT The_DT variation_NN of_IN remaining_VBG activity_NN (_( E/E0_NP )_) with_IN time_NN t_NN follows_VBZ :_: Analysis_NN of_IN data_NNS led_VBN to_TO the_DT rate_NN constant_JJ kd_NN for_IN the_DT two_CD enzymes_NNS ._SENT Placental_JJ AP_NP appears_VBZ to_TO be_VB 15_CD fold_NN more_JJR resistant_NN than_IN NSAP_NP ._SENT Figure_NP 3_CD |_SYM Inactivation_NN of_IN alkaline_JJ phosphatase_NN by_IN temperature_NN :_: effect_NN of_IN incubation_NN of_IN PLAP_NP and_CC NSAP_NP at_IN 56C_NP on_IN activity_NN ._SENT Inactivation_NN of_IN alkaline_JJ phosphatase_NN by_IN temperature_NN :_: effect_NN of_IN incubation_NN of_IN PLAP_NP and_CC NSAP_NP at_IN 56C_NP on_IN activity_NN ._SENT Comparison_NN of_IN kinetic_JJ constants_NNS of_IN NSAP_NP and_CC PLAP_NP |_SYM Hydrolysis_NN of_IN p-nitrophenylphosphate_NN by_IN the_DT two_CD recombinant_JJ enzymes_NNS did_VBD not_RB reveal_VB any_DT significant_JJ difference_NN in_IN their_PP$ affinity_NN for_IN this_DT substrate_NN ._SENT Km_NP were_VBD estimated_VBN to_TO 171_CD +/-_NN 12_CD muM_NN and_CC 180_CD +/-_NN 15_CD muM_NN respectively_RB ._SENT For_IN each_DT enzyme_NN ,_, we_PP observed_VBD a_DT decrease_NN of_IN Km_NP with_IN pH_NN (_( from_IN 9.5_CD to_TO 8_CD )_) but_CC without_IN any_DT meaningful_JJ difference_NN between_IN the_DT two_CD enzymes_NNS ._SENT Sodium_NN thiophosphate_NN is_VBZ a_DT full_JJ competitive_JJ inhibitor_NN of_IN AP_NP ,_, and_CC the_DT inhibition_NN was_VBD thus_RB studied_VBN according_VBG to_TO scheme_NN 3_CD ,_, where_WRB E_NP represents_VBZ the_DT enzyme_NN ,_, S_NP the_DT substrate_NN p-nitrophenylphosphate_NN ,_, and_CC I_PP the_DT reversible_JJ inhibitor_NN ._SENT For_IN clarity_NN ,_, free_JJ substrate_NN and_CC inhibitor_NN are_VBP omitted_VBN from_IN the_DT presentation_NN as_RB are_VBP the_DT products_NNS ._SENT Variation_NN of_IN the_DT hydrolysis_NN rate_NN of_IN the_DT substrate_NN (_( v_NN )_) with_IN substrate_NN and_CC inhibitor_NN concentrations_NNS follows_VBZ equation_NN 3_LS :_: Placental_JJ AP_NP was_VBD more_JJR than_IN four_CD times_NNS more_RBR sensitive_JJ to_TO this_DT inhibitor_NN than_IN NSAP_NP ._SENT Figure_NP 4_CD |_SYM Inhibition_NN of_IN PLAP_NP and_CC NSAP_NP by_IN thiophosphate_NN ._SENT Inhibition_NN of_IN PLAP_NP and_CC NSAP_NP by_IN thiophosphate_NN ._SENT L-p-bromotetramisole_NP is_VBZ an_DT uncompetitive_NN inhibitor_NN specific_JJ for_IN alkaline_JJ phosphatase_NN ,_, it_PP binds_VBZ to_TO the_DT phosphorylenzyme_NN intermediate_JJ preventing_VBG dephosphorylation_NN as_IN phenylalanine_NN ._SENT Binding_VBG of_IN inhibitor_NN is_VBZ shown_VBN on_IN scheme_NN 4_CD ,_, where_WRB E_NP represents_VBZ the_DT free_JJ enzyme_NN ;_: ES_NP ,_, the_DT Michaelian_NP complex_NN ;_: EX_NN the_DT phophorylenzyme_NN and_CC EXI_NP ,_, the_DT inhibitor_NN bound_VBN on_IN the_DT phosphoryl_NN enzyme_NN ._SENT The_DT variation_NN of_IN the_DT hydrolysis_NN rate_NN of_IN the_DT substrate_NN (_( v_NN )_) with_IN substrate_NN and_CC inhibitor_NN concentrations_NNS follows_VBZ equation_NN 4_CD :_: L-p-bromotetramisole_NP appeared_VBD to_TO be_VB a_DT potent_JJ inhibitor_NN of_IN the_DT two_CD enzymes_NNS ._SENT Placental_JJ AP_NP was_VBD more_RBR sensitive_JJ than_IN NSAP_NP ._SENT Figure_NP 5_CD |_SYM Inhibition_NN of_IN PLAP_NP and_CC NSAP_NP by_IN L-p-bromotetramisole_NP ._SENT Inhibition_NN of_IN PLAP_NP and_CC NSAP_NP by_IN L-p-bromotetramisole_NP ._SENT Quantification_NN of_IN NSAP_NP and_CC PLAP_NP in_IN neutrophils_NNS |_SYM Phosphatase_NN activity_NN from_IN neutrophils_NNS of_IN pregnant_JJ women_NNS with_IN a_DT normal_JJ or_CC with_IN a_DT trisomy_JJ 21_CD fetus_NN were_VBD slightly_RB different_JJ (_( 1.8_CD +/-_NN 0.4_CD and_CC 1.2_CD +/-_NN 0.2_CD n_NN I.U._NP per_IN mg_NN protein_NN ,_, p_NN =_SYM 0.0013_CD )_) ._SENT Kinetic_JJ constants_NNS were_VBD used_VBN to_TO estimate_VB the_DT relative_JJ amounts_NNS of_IN NSAP_NP and_CC PLAP_NP ._SENT As_IN the_DT greater_JJR difference_NN between_IN the_DT two_CD enzymes_NNS was_VBD the_DT resistance_NN to_TO temperature_NN denaturation_NN ,_, the_DT stability_NN of_IN neutrophil_JJ AP_NP was_VBD recorded_VBN and_CC analyzed_VBN considering_VBG that_IN there_EX was_VBD a_DT mixture_NN of_IN the_DT two_CD enzymes_NNS ._SENT Thus_RB ,_, remaining_VBG activity_NN follows_VBZ the_DT sum_NN of_IN equation_NN 2_CD weighted_VBN by_IN the_DT proportion_NN of_IN the_DT two_CD enzymes_NNS :_: where_WRB kda_NN represents_VBZ the_DT denaturation_NN rate_NN constant_JJ of_IN the_DT PLAP_NP component_NN ,_, kdb_NN ,_, the_DT denaturation_NN rate_NN constant_JJ of_IN the_DT NSAP_NP component_NN ,_, and_CC a_DT the_DT relative_JJ proportion_NN of_IN PLAP_NP ._SENT As_IN the_DT rate_NN constants_NNS were_VBD already_RB determined_VBN ,_, the_DT fit_NN allowed_VBD the_DT proportion_NN of_IN the_DT two_CD isozymes_NNS to_TO be_VB unambiguously_RB determined_VBN ._SENT In_IN non_JJ pregnant_JJ women_NNS ,_, PLAP_NP represented_VBD 13_CD %_NN of_IN the_DT total_JJ AP_NP activity_NN of_IN neutrophils_NNS ._SENT This_DT proportion_NN did_VBD not_RB significantly_RB increase_VB with_IN normal_JJ pregnancy_NN ._SENT By_IN contrast_NN ,_, in_IN pregnancies_NNS with_IN trisomy_NN 21_CD fetus_NN ,_, we_PP found_VBD a_DT mean_NN of_IN PLAP_NP of_IN 67_CD %_NN ._SENT Analysis_NN of_IN nine_CD individuals_NNS revealed_VBD that_IN PLAP_NP proportion_NN in_IN neutrophils_NNS varied_VBN from_IN 60_CD to_TO 80_CD %_NN for_IN pregnancies_NNS with_IN trisomy_JJ 21_CD ._SENT The_DT same_JJ analysis_NN was_VBD performed_VBN using_VBG the_DT differential_JJ sensitivity_NN to_TO urea_NN ,_, to_TO thiophosphate_NN and_CC to_TO tetramisole_NN and_CC the_DT same_JJ result_NN was_VBD obtained_VBN :_: the_DT proportion_NN of_IN PLAP_NN in_IN neutrophils_NNS reached_VBN 60_CD --_: 80_CD %_NN of_IN AP_NP activity_NN in_IN pregnancies_NNS with_IN a_DT trisomy_JJ 21_CD fetus_NN ._SENT Table_NP 1_CD |_SYM AP_NP activity_NN (_( nkat/mg_NN ._SENT protein_NN )_) and_CC Percentage_NN of_IN PLAP_NN in_IN neutrophils_NNS of_IN pregnant_JJ women_NNS pregnant_JJ or_CC not_RB and_CC bearing_VBG either_DT trisomy_JJ 21_CD fetus_NN or_CC normal_JJ fetus_NN ._SENT Comparison_NN of_IN alkaline_JJ phosphatase_NN isoenzymes_NNS necessitates_VBZ their_PP$ purification_NN ._SENT As_IN the_DT preparation_NN of_IN reasonable_JJ amounts_NNS of_IN purified_VBN alkaline_JJ phosphatase_NN from_IN human_JJ tissues_NNS is_VBZ a_DT rather_RB complex_JJ undertaking_NN ,_, we_PP chose_VBD to_TO express_VB two_CD isozymes_NNS in_IN vitro_NN ._SENT The_DT PLAP_NP gene_NN had_VBD been_VBN already_RB expressed_VBN in_IN vitro_NN using_VBG transfected_JJ simian_JJ cells_NNS ,_, baculovirus_NN and_CC Pichia_NP pastoris_NNS ._SENT Production_NN did_VBD not_RB significantly_RB differ_VB from_IN the_DT data_NNS reported_VBN by_IN Davies_NP et_FW al._FW ,_, i.e._FW 10_CD U/ml_NN ._SENT In_IN the_DT present_JJ study_NN ,_, NSAP_NP was_VBD produced_VBN in_IN baculovirus_JJ infected_JJ cells_NNS but_CC expression_NN was_VBD weak_JJ ,_, about_RB 5-fold_NN lower_JJR than_IN the_DT expression_NN obtained_VBN with_IN PLAP_NP ._SENT The_DT lower_JJR stability_NN of_IN NSAP_NP compared_VBN to_TO PLAP_NP may_MD contribute_VB to_TO this_DT under-expression_NN of_IN the_DT NSAP_NP isozyme_NN ._SENT The_DT kinetics_NNS of_IN urea_NN denaturation_NN distinguish_VB the_DT two_CD isoenzymes_NNS ._SENT Denaturation_NN appeared_VBD to_TO be_VB monophasic_JJ in_IN this_DT study_NN for_IN the_DT two_CD enzymes_NNS ._SENT This_DT is_VBZ not_RB in_IN contradiction_NN with_IN the_DT report_NN of_IN Hung_NP and_CC Chang_NP who_WP evidenced_VBD a_DT biphasic_JJ denaturation_NN of_IN the_DT enzyme_NN because_IN in_IN the_DT first_JJ denaturation_NN phase_NN ,_, the_DT enzyme_NN remains_VBZ fully_RB active_JJ ,_, thus_RB this_DT step_NN was_VBD not_RB analysed_VBN in_IN the_DT present_JJ study_NN ._SENT The_DT relative_JJ resistance_NN of_IN PLAP_NN to_TO denaturation_NN has_VBZ been_VBN known_VBN for_IN a_DT long_JJ time_NN ._SENT Here_RB we_PP confirm_VBP this_DT result_NN and_CC we_PP show_VBP that_IN the_DT stability_NN originates_VBZ from_IN a_DT decrease_NN of_IN the_DT rate_NN of_IN the_DT denaturation_NN step_NN leading_VBG to_TO reversible_JJ non_JJ active_JJ form_NN ._SENT The_DT renaturation_NN rate_NN constant_JJ of_IN the_DT two_CD enzymes_NNS were_VBD not_RB significantly_RB different_JJ ._SENT PLAP_NP also_RB appeared_VBD to_TO be_VB more_RBR stable_JJ than_IN NSAP_NP to_TO temperature_NN denaturation_NN as_IN first_RB described_VBN by_IN McMaster_NP et_FW al._FW and_CC since_RB repeatedly_RB confirmed_VBN ._SENT As_RB for_IN urea_NN denaturation_NN ,_, the_DT stability_NN seems_VBZ to_TO originate_VB from_IN a_DT lower_JJR rate_NN of_IN the_DT reversible_JJ denaturation_NN while_IN the_DT denaturation_NN rate_NN constants_NNS leading_VBG to_TO an_DT irreversible_JJ denatured_VBN form_NN were_VBD not_RB significantly_RB different_JJ ._SENT As_IN denaturation_NN of_IN AP_NP depends_VBZ on_IN the_DT incubation_NN buffer_NN ,_, we_PP may_MD hypothesize_VB that_IN it_PP would_MD be_VB possible_JJ to_TO find_VB conditions_NNS for_IN which_WDT differences_NNS in_IN denaturation_NN between_IN the_DT two_CD enzymes_NNS are_VBP still_RB more_RBR pronounced_JJ ._SENT By_IN comparison_NN with_IN the_DT GCAP_NP isozyme_NN ,_, which_WDT differs_VBZ from_IN PLAP_NP by_IN only_RB 7_CD aminoacids_NNS ,_, Watanabe_NP et_FW al._FW identified_VBN glutamate_NN 429_CD as_IN the_DT main_JJ amino-acid_NN responsible_JJ for_IN the_DT relatively_RB high_JJ stability_NN of_IN PLAP_NP ._SENT The_DT Km_NP of_IN PLAP_NP for_IN p-nitrophenylphosphate_NN was_VBD slightly_RB lower_JJR than_IN the_DT Km_NP found_VBD by_IN Chang_NP et_FW al._FW ._SENT Determination_NN of_IN Km_NP with_IN the_DT human_JJ enzyme_NN from_IN the_DT same_JJ source_NN (_( Sigma_NP )_) confirmed_VBD this_DT difference_NN suggesting_VBG that_IN it_PP rather_RB originates_VBZ from_IN experimental_JJ conditions_NNS than_IN from_IN the_DT in_IN vitro_NN expression_NN of_IN the_DT enzyme_NN ._SENT L-p-bromotetramisole_NP appeared_VBD to_TO be_VB a_DT potent_JJ inhibitor_NN to_TO AP_NP with_IN a_DT slight_JJ specificity_NN for_IN PLAP_NP compared_VBN to_TO NSAP_NP ._SENT This_DT result_NN is_VBZ in_IN contrast_NN with_IN the_DT data_NNS available_JJ for_IN levamisole_NN which_WDT ,_, although_IN related_VBN to_TO L-p-bromotetramisole_NP ,_, is_VBZ known_VBN to_TO be_VB specific_JJ of_IN NSAP_NP ._SENT NSAP_NP activity_NN of_IN neutrophils_NNS have_VBP been_VBN reported_VBN to_TO increase_VB during_IN pregnancy_NN ,_, and_CC presence_NN of_IN a_DT heat_NN stable_JJ AP_NP in_IN neutrophils_NNS can_MD be_VB a_DT useful_JJ marker_NN for_IN the_DT screening_NN of_IN trisomy_NN 21_CD fetuses_NNS ._SENT We_PP sequenced_VBD the_DT neutrophil_JJ NSAP_NP phosphatase_NN from_IN trisomy_JJ 21_CD pregnant_JJ women_NNS and_CC trisomy_JJ 21_CD children_NNS but_CC no_DT mutation_NN was_VBD detected_VBN indicating_VBG that_IN the_DT differences_NNS in_IN alkaline_JJ phosphatase_NN characteristics_NNS do_VBP not_RB originate_VB from_IN a_DT mutant_JJ allele_NN of_IN the_DT non_JJ specific_JJ alkaline_JJ phosphatase_NN gene_NN (_( unpublished_JJ data_NNS )_) ._SENT This_DT suggests_VBZ that_IN the_DT heat_NN stability_NN of_IN neutrophil_JJ AP_NP associated_VBN with_IN Down_NP 's_POS syndrome_NN may_MD originate_VB from_IN the_DT relative_JJ expression_NN of_IN PLAP_NP and_CC NSAP_NP ._SENT Our_PP$ results_NNS might_MD indicate_VB that_IN PLAP_NP is_VBZ expressed_VBN in_IN neutrophils_NNS and_CC its_PP$ proportion_NN increases_NNS in_IN Down_NP 's_POS syndrome_NN pregnancy_NN ._SENT However_RB ,_, this_DT conclusion_NN is_VBZ in_IN contradiction_NN with_IN the_DT report_NN of_IN Peleg_NP et_FW al._FW which_WDT reported_VBD no_DT difference_NN in_IN AP_NP stability_NN in_IN neutrophils_NNS of_IN pregnant_JJ women_NNS bearing_VBG a_DT trisomy_JJ 21_CD fetus_NN ._SENT Among_IN the_DT hypotheses_NNS which_WDT can_MD be_VB proposed_VBN ,_, loss_NN of_IN the_DT PLAP_NP component_NN during_IN enzyme_NN preparation_NN is_VBZ possible_JJ since_IN the_DT authors_NNS discarded_VBD soluble_JJ proteins_NNS ._SENT The_DT presence_NN of_IN PLAP_NP can_MD be_VB used_VBN in_IN conjunction_NN with_IN other_JJ markers_NNS in_IN the_DT serum_NN of_IN mothers_NNS which_WDT are_VBP currently_RB used_VBN to_TO detect_VB Down_NP 's_POS syndrome_NN ._SENT The_DT screening_NN procedure_NN using_VBG the_DT serum_NN concentration_NN of_IN alpha-fetoprotein_NN ,_, human_JJ chorionic_JJ gonadotropin_NN ,_, pregnancy-associated_JJ plasma_NN protein-A_NN and_CC unconjugated_JJ oestriol_NN combined_VBN with_IN nuchal_JJ translucency_NN has_VBZ a_DT detection_NN rate_NN of_IN 85_CD --_: 90_CD per_IN cent_NN with_IN 5_CD per_IN cent_NN false_JJ positives_NNS ._SENT So_RB ,_, using_VBG the_DT presence_NN of_IN PLAP_NN in_IN neutrophils_NNS might_MD improve_VB the_DT detection_NN rate_NN ._SENT Is_VBZ the_DT presence_NN of_IN PLAP_NN in_IN neutrophils_NNS due_JJ to_TO the_DT actual_JJ existence_NN of_IN a_DT trisomy_JJ 21_CD fetus_NN ?_SENT or_CC is_VBZ the_DT presence_NN of_IN PLAP_NN in_IN neutrophils_NNS responsible_JJ for_IN a_DT predisposition_NN of_IN trisomy_NN 21_CD pregnancy_NN ?_SENT As_IN neutrophils_NNS of_IN trisomy_NN 21_CD patients_NNS contain_VBP only_RB NSAP_NP ,_, we_PP can_MD reject_VB the_DT second_JJ hypothesis_NN ._SENT Then_RB the_DT presence_NN of_IN PLAP_NN in_IN neutrophils_NNS is_VBZ not_RB genetically_RB determined_VBN and_CC seems_VBZ to_TO be_VB a_DT consequence_NN of_IN the_DT presence_NN of_IN a_DT trisomy_JJ 21_CD fetus_NN ._SENT Subjects_NNS and_CC sample_NN isolation_NN |_SYM Nine_CD blood_NN samples_NNS from_IN unrelated_JJ women_NNS bearing_VBG a_DT fetus_NN with_IN trisomy_JJ 21_CD were_VBD examined_VBN ._SENT Patients_NNS were_VBD 36_CD +/-_NN 6_CD years_NNS of_IN age_NN ._SENT Blood_NN was_VBD collected_VBN during_IN weeks_NNS 19_CD and_CC 20_CD of_IN gestation_NN following_VBG amniocentesis_NN and_CC karyotyping_NN ._SENT Two_CD control_NN groups_NNS ,_, with_IN same_JJ number_NN of_IN samples_NNS from_IN women_NNS of_IN the_DT same_JJ age_NN and_CC at_IN the_DT same_JJ gestational_JJ age_NN were_VBD done_VBN :_: pregnant_JJ women_NNS with_IN normal_JJ pregnancy_NN and_CC not-pregnant_JJ women_NNS ._SENT The_DT permission_NN of_IN all_DT patients_NNS was_VBD obtained_VBN before_IN blood_NN was_VBD collected_VBN ._SENT Neutrophils_NNS were_VBD immediately_RB isolated_VBN by_IN the_DT procedure_NN of_IN Gainer_NP and_CC Stinson_NP ._SENT Extraction_NN of_IN the_DT enzyme_NN was_VBD immediately_RB performed_VBN after_IN blood_NN taking_VBG and_CC carried_VBD out_RP in_IN 25_CD mM_NP phosphate_NN buffer_NN pH7_JJ in_IN the_DT presence_NN of_IN 2_CD %_NN Triton_NP X-100_NP ._SENT The_DT cells_NNS were_VBD sonicated_VBN and_CC the_DT homogenate_NN spun_VBN at_IN 10_CD krpm_NN ,_, 1_CD hour_NN at_IN 2C_JJ ._SENT The_DT clear_JJ supernatant_JJ was_VBD collected_VBN and_CC frozen_VBN at_IN -20C_NN before_IN biochemical_JJ determination_NN for_IN less_JJR than_IN three_CD days_NNS ._SENT Preliminary_JJ experiments_NNS showed_VBD that_DT congelation_NN in_IN these_DT conditions_NNS did_VBD not_RB affect_VB the_DT phosphatase_NN activity_NN ._SENT In_IN vitro_NN gene_NN expression_NN and_CC protein_NN purification_NN |_SYM The_DT NSAP_NP encoding_VBG gene_NN was_VBD cloned_VBN by_IN RT-PCR_NP and_CC inserted_VBN into_IN the_DT baculovirus_NN transfer_NN vector_NN pBacPaK9_NN (_( Clontech_NP )_) ._SENT Recombination_NN in_IN the_DT virus_NN BacPAK6_NP was_VBD performed_VBN by_IN standard_JJ protocols_NNS ._SENT The_DT placental_JJ AP_NP was_VBD produced_VBN form_NN the_DT recombinant_JJ baculovirus_NN constructed_VBN by_IN Davis_NP et_FW al._FW ._SENT Enzymes_NNS were_VBD partially_RB purified_VBN on_IN DEAE_NP columns_NNS and_CC precipitated_VBD by_IN acetone_NN according_VBG to_TO Masuhara_NP et_FW al._FW ._SENT AP_NP assays_NNS and_CC kinetic_JJ measurements_NNS |_SYM Kinetic_JJ measurements_NNS were_VBD performed_VBN in_IN triplicate_NN at_IN 37C_JJ ,_, at_IN pH_NN 9.5_CD in_IN 0.1_CD mol/L_NN diethanolamine-HCl_NN buffer_NN containing_VBG 45_CD mmol/L_NN MgCl2_NN ,_, with_IN an_DT ionic_JJ strength_NN maintained_VBD constant_JJ (_( 0.2_CD )_) with_IN NaCl_NP ,_, using_VBG sodium_NN p-nitrophenylphosphate_NN as_IN substrate_NN ._SENT The_DT amount_NN of_IN reaction_NN product_NN (_( paranitrophenate_NN )_) was_VBD quantified_VBN using_VBG absorption_NN at_IN 400_CD nm_NN (_( apparent_JJ epsilon_NN =_SYM 18500_CD L.mol-1.cm-1_NN at_IN pH_NN 9.5_CD )_) ._SENT All_PDT the_DT kinetics_NNS were_VBD carried_VBN out_RP for_IN at_IN least_JJS 5_CD minutes_NNS and_CC the_DT initial_JJ velocities_NNS determined_VBN by_IN the_DT slopes_NNS using_VBG the_DT software_NN included_VBD in_IN the_DT Perkin_NP Elmer_NP UV-Visible_NP spectrophotometer_NN Lamda_NP 15_CD ._SENT The_DT reversible_JJ inhibitors_NNS sodium_NN thiophosphate_NN and_CC L-p-bromotetramisole_NP (_( 2,3,5,6-tetrahydro-6-phenylimidazo-[2,1-b]-thiazol_NP ;_: Fig._NN )_) were_VBD incubated_VBN for_IN five_CD minutes_NNS with_IN the_DT enzyme_NN before_IN the_DT addition_NN of_IN substrate_NN ._SENT Data_NNS were_VBD analysed_VBN by_IN multiple_JJ nonlinear_JJ regression_NN using_VBG a_DT non-linear_JJ global_JJ optimization_NN method_NN based_VBN on_IN simulated_VBN annealing_VBG (_( J._NP Czaplicki_NP ,_, V._NP Marcel_NP and_CC D._NP Fournier_NP ,_, manuscript_NN in_IN preparation_NN )_) with_IN equations_NNS solved_VBD according_VBG to_TO the_DT rapid_JJ equilibrium_NN hypothesis_NN ._SENT Figure_NP 1_CD |_SYM Inhibitors_NNS and_CC substrate_NN used_VBD ._SENT Inhibitors_NNS and_CC substrate_NN used_VBD ._SENT Stability_NN of_IN enzymes_NNS and_CC sensitivity_NN to_TO inhibitors_NNS |_SYM For_IN inactivation_NN studies_NNS ,_, the_DT concentration_NN of_IN native_JJ enzyme_NN was_VBD calculated_VBN from_IN the_DT residual_JJ activity_NN after_IN preincubation_NN of_IN the_DT protein_NN either_CC with_IN urea_NN or_CC at_IN high_JJ temperature_NN ,_, without_IN substrate_NN ._SENT Urea_NN denaturation_NN was_VBD carried_VBN out_RP by_IN incubating_VBG each_DT protein_NN with_IN freshly_RB 7.4_CD M_NN urea_NN solution_NN in_IN 0.1_CD mol/L_NN diethanolamine-HCl_NN buffer_NN pH_NN 9.5_CD ,_, 45_CD mmol/L_NN MgCl2_NP ,_, 0.2_CD ionic_JJ strength_NN at_IN 20C_JJ for_IN 30_CD minutes_NNS ._SENT The_DT variation_NN of_IN the_DT remaining_VBG proportion_NN of_IN non-denatured_JJ enzyme_NN with_IN time_NN was_VBD estimated_VBN by_IN sampling_VBG aliquots_NNS every_DT five_CD minutes_NNS and_CC recording_VBG the_DT remaining_VBG activity_NN ._SENT As_IN a_DT control_NN ,_, the_DT remaining_VBG activity_NN was_VBD determined_VBN by_IN incubation_NN of_IN proteins_NNS without_IN urea_NN ._SENT Heat_NN inactivation_NN used_VBD the_DT same_JJ protocol_NN but_CC incubation_NN was_VBD at_IN 56C_NP ,_, 65C_NP or_CC 70C_NP ._SENT As_IN the_DT results_NNS obtained_VBN at_IN the_DT three_CD temperature_NN are_VBP in_IN accordance_NN ,_, only_RB the_DT results_NNS obtained_VBN at_IN 56C_NP are_VBP presented_VBN ._SENT 